Patrick Morris
President chez Paragon Biosciences Emalex Capital, Inc.
Profil
Patrick J.
Morris is currently serving as the President, Secretary & Director at Paragon Biosciences Emalex Capital, Inc., the President, Secretary, Treasurer & Director at Paragon Biosciences Skyline Capital LLC, the President, Secretary & Director at Paragon Biosciences Qlarity Capital, Inc., the Director at Castle Creek Biosciences, Inc., the President, Director, Executive VP & Manager at Paragon Biosciences Evozyne Capital LLC, the President, Secretary, Director & EVP-Legal Affairs at Paragon Biosciences Evozyne Holdings LLC, and the President, Secretary, General Counsel & Director at CIRC Biosciences, Inc.Mr. Morris previously worked as a Partner at Katten Muchin Rosenman LLP.
From 2003 to 2010, he served as the Vice President-Legal Affairs & General Counsel at OVATION Pharmaceuticals, Inc. He also held the position of Executive VP-Legal Affairs & General Counsel at Marathon Pharmaceuticals LLC.
Mr. Morris completed his undergraduate degree at DePaul University in 1989.
He then pursued his graduate studies at Northwestern University School of Law.
Postes actifs de Patrick Morris
| Sociétés | Poste | Début |
|---|---|---|
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Director/Board Member | - |
Paragon Biosciences Emalex Capital, Inc.
 Paragon Biosciences Emalex Capital, Inc. Pharmaceuticals: MajorHealth Technology Paragon Biosciences Emalex Capital, Inc. provides pharmaceuticals services. The company is headquartered in Northbrook, IL. | President | - |
Paragon Biosciences Qlarity Capital, Inc.
 Paragon Biosciences Qlarity Capital, Inc. Pharmaceuticals: MajorHealth Technology Paragon Biosciences Qlarity Capital, Inc. provides pharmaceutical services. The company was founded in 2018 and is headquartered in Chicago, IL. | President | - |
Paragon Biosciences Evozyne Capital LLC
 Paragon Biosciences Evozyne Capital LLC Miscellaneous Commercial ServicesCommercial Services Paragon Biosciences Evozyne Capital LLC engages in the development of novel medicines. The company is headquartered in Chicago, IL. | President | - |
Paragon Biosciences Evozyne Holdings LLC
 Paragon Biosciences Evozyne Holdings LLC Paragon Biosciences Evozyne Holdings LLC engages in the biotechnology business. The company is headquartered in Chicago, IL. | President | - |
Paragon Biosciences Skyline Capital LLC
 Paragon Biosciences Skyline Capital LLC Pharmaceuticals: MajorHealth Technology Paragon Biosciences Skyline Capital LLC engages in the provision of pharmaceutical services. The company is headquartered in Northbrook, IL. | President | - |
CIRC Biosciences, Inc.
 CIRC Biosciences, Inc. BiotechnologyHealth Technology CIRC Biosciences, Inc. is a privately held cell therapy company that focuses on developing treatments for serious diseases with high unmet needs. The company is based in Dallas, TX. The company's initial focus is on the eye. The company was founded by Jeffrey S. Aronin. | President | - |
Anciens postes connus de Patrick Morris
| Sociétés | Poste | Fin |
|---|---|---|
OVATION Pharmaceuticals, Inc.
 OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | General Counsel | 29/03/2010 |
Marathon Pharmaceuticals LLC
 Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Marathon Pharmaceuticals LLC is a holding company, which develops and manufactures pharmaceutical products. Its products include treatment for neurological disorders, rare cancers, and preanesthetics. The company was founded in 2008 and is headquartered in Northbrook, IL. | General Counsel | - |
| ░░░░░░ ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Patrick Morris
| DePaul University | Undergraduate Degree |
| Northwestern University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Katten Muchin Rosenman LLP
 Katten Muchin Rosenman LLP Miscellaneous Commercial ServicesCommercial Services Katten Muchin Rosenman LLP provides legal services. The firm specializes in corporate, financial services, litigation, real estate, commercial finance, intellectual property, trusts and estates, antitrust, bankruptcy, international trade, employee benefits and executive compensation, employment, environmental, public finance and tax. The company was founded in 1974 and is headquartered in Chicago, IL. | Commercial Services |
OVATION Pharmaceuticals, Inc.
OVATION Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OVATION Pharmaceuticals, Inc. develops, manufactures and markets pharmaceuticals. It focuses on central nervous system, hematology or oncology and hospital-based therapies. The company was founded by Jeffrey S. Aronin in 2000 and is headquartered in Deerfield, IL. | Health Technology |
Marathon Pharmaceuticals LLC
Marathon Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Marathon Pharmaceuticals LLC is a holding company, which develops and manufactures pharmaceutical products. Its products include treatment for neurological disorders, rare cancers, and preanesthetics. The company was founded in 2008 and is headquartered in Northbrook, IL. | Health Technology |
Paragon Biosciences Emalex Capital, Inc.
Paragon Biosciences Emalex Capital, Inc. Pharmaceuticals: MajorHealth Technology Paragon Biosciences Emalex Capital, Inc. provides pharmaceuticals services. The company is headquartered in Northbrook, IL. | Health Technology |
Paragon Biosciences Skyline Capital LLC
Paragon Biosciences Skyline Capital LLC Pharmaceuticals: MajorHealth Technology Paragon Biosciences Skyline Capital LLC engages in the provision of pharmaceutical services. The company is headquartered in Northbrook, IL. | Health Technology |
Paragon Biosciences Qlarity Capital, Inc.
Paragon Biosciences Qlarity Capital, Inc. Pharmaceuticals: MajorHealth Technology Paragon Biosciences Qlarity Capital, Inc. provides pharmaceutical services. The company was founded in 2018 and is headquartered in Chicago, IL. | Health Technology |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |
Paragon Biosciences Evozyne Capital LLC
Paragon Biosciences Evozyne Capital LLC Miscellaneous Commercial ServicesCommercial Services Paragon Biosciences Evozyne Capital LLC engages in the development of novel medicines. The company is headquartered in Chicago, IL. | Commercial Services |
Paragon Biosciences Evozyne Holdings LLC
Paragon Biosciences Evozyne Holdings LLC Paragon Biosciences Evozyne Holdings LLC engages in the biotechnology business. The company is headquartered in Chicago, IL. | |
CIRC Biosciences, Inc.
CIRC Biosciences, Inc. BiotechnologyHealth Technology CIRC Biosciences, Inc. is a privately held cell therapy company that focuses on developing treatments for serious diseases with high unmet needs. The company is based in Dallas, TX. The company's initial focus is on the eye. The company was founded by Jeffrey S. Aronin. | Health Technology |
